Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?
about
Hypoxia-inducible factor 1 and breast cancer metastasisBuilding pathway clusters from Random Forests classification using class votesHypoxia increases the metastatic ability of breast cancer cells via upregulation of CXCR4Positive correlation between the expression of hEag1 and HIF-1α in breast cancers: an observational study.Molecular pathogenesis of bone metastases in breast cancer: Proven and emerging therapeutic targetsHIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer - a study of the OVCAD ConsortiumSNP 1772 C > T of HIF-1α gene associates with breast cancer risk in a Taiwanese population.Hypoxia promotes migration and induces CXCR4 expression via HIF-1α activation in human osteosarcoma.Expression of Hypoxia-inducible factor 1-α and vascular endothelial growth factor-C in locally advanced breast cancer patients.Regulation of anti-apoptotic signaling by Kruppel-like factors 4 and 5 mediates lapatinib resistance in breast cancer.Gene expression and hypoxia in breast cancer.HSET overexpression fuels tumor progression via centrosome clustering-independent mechanisms in breast cancer patientsStrong Expression of Hypoxia-Inducible Factor-1α (HIF-1α) Is Associated with Axl Expression and Features of Aggressive Tumors in African Breast Cancer.Oxidative stress promotes myofibroblast differentiation and tumour spreading.Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancerTumor recovery by angiogenic switch from sprouting to intussusceptive angiogenesis after treatment with PTK787/ZK222584 or ionizing radiationCisplatin treatment increases stemness through upregulation of hypoxia-inducible factors by interleukin-6 in non-small cell lung cancer.Quantitative [18F]FMISO PET Imaging Shows Reduction of Hypoxia Following Trastuzumab in a Murine Model of HER2+ Breast Cancer.Targeting the hypoxia-inducible factor (HIF) pathway in cancer.Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.Prognostic value of plasma levels of HIF-1a and PGC-1a in breast cancer.Prolyl hydroxylase and hypoxia inducible factor: potential targets for cancer therapy.Tumour oxygenation: implications for breast cancer prognosis.Hypoxia and DNA repair.Overexpression of MMP-9 and HIF-1α in Breast Cancer Cells under Hypoxic Conditions.Overexpression of hypoxia-inducible factor-1alpha in human osteosarcoma: correlation with clinicopathological parameters and survival outcome.Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1alpha-mediated invasion of breast carcinoma cells.Extracellular matrix and HIF-1 signaling: the role of prolidase.Hypoxia-inducible factor 1 alpha promotes cancer stem cells-like properties in human ovarian cancer cells by upregulating SIRT1 expressionHypoxia-inducible factor-1α overexpression indicates poor clinical outcomes in tongue squamous cell carcinomaHypoxia-inducible factor prolyl hydroxylase 2 (PHD2) is a direct regulator of epidermal growth factor receptor (EGFR) signaling in breast cancer.Association of choline levels and tumor perfusion in brain metastases assessed with proton MR spectroscopy and dynamic susceptibility contrast-enhanced perfusion weighted MRI.Low expression of Beclin 1 and elevated expression of HIF-1α refine distant metastasis risk and predict poor prognosis of ER-positive, HER2-negative breast cancer.Expression of HIF-1? in human tumours.Applications of "Hot" and "Cold" Bis(thiosemicarbazonato) Metal Complexes in Multimodal Imaging.Expression of multidrug resistance protein P-glycoprotein in correlation with markers of hypoxia (HIF-1α, EPO, EPO-R) in invasive breast cancer with metastasis to lymph nodes.CoCl2 increases the expression of hypoxic markers HIF-1α, VEGF and CXCR4 in breast cancer MCF-7 cells.HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.ΔNp73 enhances HIF-1α protein stability through repression of the ECV complex.The ERβ4 variant induces transformation of the normal breast mammary epithelial cell line MCF-10A; the ERβ variants ERβ2 and ERβ5 increase aggressiveness of TNBC by regulation of hypoxic signaling.
P2860
Q28087393-7D186AA9-F4C4-4563-983F-D7BB9C2CB1FDQ33318578-DC81E015-83AA-4807-87CF-E152DE190936Q33584212-F4CA288A-61A4-4CD6-84EE-54E956531D62Q33629346-072232A5-2315-4B1C-B5F2-C45BC7DBEF92Q34023663-E66CCA46-AF8E-444E-B045-AA6576E7E970Q34198666-E263736F-D3D8-4B59-9A9E-B7ABB872C414Q34308729-F133DFE4-BEAA-4FC8-BB02-F5449D7FDD5DQ35117825-FB1F70E4-4963-49D8-9A6E-AFF7016FF262Q35179664-F9AEF0D5-467D-4A83-A02F-E457C6ADFE45Q35274741-4D9246C3-CB17-449F-BE97-F827EF44747DQ35614451-D634649F-1B98-4554-8086-3B1E7DEF3613Q35742468-2DBA3B84-5FD2-4AA2-B9C1-C5AA1D4EB7C0Q35892646-C72D724B-F697-46C3-9A0B-2E31C6AA2FA1Q36039273-40DADF0F-3C97-4E37-97C9-A5AB9E4469F8Q36614929-DA6C6DFC-5358-4862-B66B-7A1B95F1D813Q36891571-130E0251-F7DE-4741-B5AC-92AAE88CDB72Q37142438-25D5381F-2BFA-49AB-80EC-2A3D9190793DQ37559704-865A3AB6-4A03-457F-BC47-83EC13E2F154Q37587446-B2A1C3A8-E7B1-40B4-AA1A-6D1516EDCCF8Q37617542-44B50EBE-A4D2-4460-97B8-20E91044DCE5Q37718440-675D7FC6-5533-432C-A87A-C3F780968845Q37827854-669E2860-848E-4639-A952-613B7F2D7692Q38120823-68FAB427-A122-4198-B2C2-2B150C628CB3Q39042366-274143F5-FAA9-49D8-90F1-31FE05A4C0DDQ39716859-42C9FDDA-3DF4-4BD3-8CE1-EDAD23CC4A6AQ39782676-11A92635-7969-4CDB-9DAF-87442A8EF135Q39869337-EFBCFE1B-7409-4CFF-B765-A988799E9745Q40052645-2C54FDD2-CD66-440B-BD2A-FCF447EFDF25Q41636977-7BD74E30-1837-4C84-80FE-7D55D419F0E2Q41946921-307D7BBD-0FB8-4EB3-9FA9-3FBBB3346F90Q42315804-0B654EED-385E-46CB-AF5B-CF3B96B63834Q42971957-65E8B2A5-B9E3-4E83-B7B9-D2C71275FCC1Q45266784-CCC47705-7677-4E7C-A021-42EC7B7A533DQ45758454-72018D55-F7D8-4D06-AC46-42F5E4905552Q46552901-8C6063B7-3A7F-4349-A3CF-93E309A43C38Q47140172-8939E95D-940E-489F-9691-D3208829E74EQ49386878-73B9047F-1930-4BB0-B2A8-20D28A2B9377Q51996253-A59EC739-5079-4AD4-A3B8-56109855A32BQ52328692-1BF26263-C4E5-48BF-B563-A808457AEA4AQ52649598-084F73D2-9525-4C7D-9AAD-A951A409F594
P2860
Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?
description
2004 nî lūn-bûn
@nan
2004 թուականին հրատարակուած գիտական յօդուած
@hyw
2004 թվականին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Hypoxia-inducible factor 1 alp ...... ependent prognostic parameter?
@ast
Hypoxia-inducible factor 1 alp ...... ependent prognostic parameter?
@en
Hypoxia-inducible factor 1 alp ...... ependent prognostic parameter?
@nl
type
label
Hypoxia-inducible factor 1 alp ...... ependent prognostic parameter?
@ast
Hypoxia-inducible factor 1 alp ...... ependent prognostic parameter?
@en
Hypoxia-inducible factor 1 alp ...... ependent prognostic parameter?
@nl
prefLabel
Hypoxia-inducible factor 1 alp ...... ependent prognostic parameter?
@ast
Hypoxia-inducible factor 1 alp ...... ependent prognostic parameter?
@en
Hypoxia-inducible factor 1 alp ...... ependent prognostic parameter?
@nl
P2093
P2860
P3181
P356
P1476
Hypoxia-inducible factor 1 alp ...... ependent prognostic parameter?
@en
P2093
Daniel M Aebersold
Gilles Berclaz
Günther Gruber
Hans J Altermatt
Richard H Greiner
Ruslan Hlushchuk
Valentin Djonov
P2860
P2888
P304
P3181
P356
10.1186/BCR775
P407
P577
2004-01-01T00:00:00Z
P5875
P6179
1043873668